The Motley Fool

Here’s what I’d do if the FTSE 100 heads below 6,000 points

Image source: Getty Images.

What a week it’s been for the FTSE 100 in the wake of the growing coronavirus crisis. From a few points above 7,400 at the end of the previous week, the index dipped below 6,500 points on Friday. That’s a 12% fall in a week, which is huge.

Could it get worse? If we see anything close to the same bearishness next week, I wouldn’t bet against the FTSE 100 dropping below 6,000 points.

5G is here – and shares of this ‘sleeping giant’ could be a great way for you to potentially profit!

According to one leading industry firm, the 5G boom could create a global industry worth US$12.3 TRILLION out of thin air…

And if you click here we’ll show you something that could be key to unlocking 5G’s full potential...

But what should we do about it? I say the first thing we shouldn’t do is what everyone else seems to be doing. So don’t panic.

Whenever stock markets are hit by some sort of catastrophe, two things happen that I think those with calmer heads should avoid.


Even if there’s a genuine threat, investors tend to sell off everything regardless.

Look back at the banking crisis. Banks and other financial institutions were hit hard, and many still haven’t recovered to this day. But shares in hundreds of other companies saw big falls too. And that includes many that were not harmed by the financial crisis in the slightest.

If the coronavirus threat is not contained and we suffer a full-blown pandemic, do you really think that will damage the long-term business of Royal Dutch Shell? I don’t. I think the world will be just as hungry for energy this year, next year, and in five years time as if the virus had never emerged.

And what about, say, AstraZeneca and GlaxoSmithKline? Will the world stop needing drugs for all of the diseases of the developing and developed world? No, of course not.

So one thing we can do is try to identify those stocks that should be resilient in the face of a pandemic. But for many, that won’t be clear.


The second thing is that investors over-react and push prices down too far. It happens even with stocks that suffer genuine business harm, so even they can be worth buying. And whenever there’s a crash, markets invariably recover, demonstrating that we should be buying during downturns rather than selling.

There’s some rationality to the overselling and resulting exaggerated bottom, and it’s down to timing. Just knowing that shares are falling can, in itself, be enough to prompt people to sell shares. I mean, if your shares have lost 10% this week, it’s surely better to sell out before they lose another 10% next week, isn’t it?

The problem is, getting the timing right is notoriously hard. And those who try to sell when shares are falling but before they hit bottom, and buy when they’re climbing but before they reach a peak… well, they’re rarely successful in the long term.


So what am I really going to do if the FTSE 100 drops below 6,000 points? Sorry to be boring, but I’m just going to do exactly the same as I’d do at any other level.

I’m keeping up to date with my watch list, and every time I have a suitable sum to invest, I’ll pick whichever looks the best value at the time. And if the FTSE falls, I’ll get even better value.

“This Stock Could Be Like Buying Amazon in 1997”

I'm sure you'll agree that's quite the statement from Motley Fool Co-Founder Tom Gardner.

But since our US analyst team first recommended shares in this unique tech stock back in 2016, the value has soared.

What's more, we firmly believe there's still plenty of upside in its future. In fact, even throughout the current coronavirus crisis, its performance has been beating Wall St expectations.

And right now, we're giving you a chance to discover exactly what has got our analysts all fired up about this niche industry phenomenon, in our FREE special report, A Top US Share From The Motley Fool.

Click here to claim your copy now — and we’ll tell you the name of this Top US Share… free of charge!

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.